Management completed the annual impairment analysis of goodwill using a third-party quantitative assessment as of March 1, 2026. Management utilized a third-party to quantitatively assess its Food Safety and Animal Safety reporting units. Based on the results of the analysis, the fair value of the Food Safety and Animal Safety reporting units exceeded their carrying values as of March 1, 2026. Therefore, the annual impairment analysis resulted in no impairment for 2026.

In the second quarter of fiscal year 2025, the Company identified that the impact of integration challenges and end market conditions on the recent overall financial performance of the Food Safety reporting unit represented a triggering event to test goodwill within that reporting unit for impairment as of the first day of the second quarter of fiscal year 2025. Management utilized a third-party to quantitatively assess its Food Safety reporting unit. Based on the results of the analysis, the carrying value of the Food Safety reporting unit exceeded its fair value. Accordingly, an impairment charge of $461.4 million was recorded. Differences in the balance sheet change and impairment charge are due to foreign exchange.

Management also completed the annual impairment analysis of goodwill using a third-party quantitative assessment as of March 1, 2025. Management utilized a third-party to quantitatively assess its Food Safety and Animal Safety reporting units. Based on the results of the analysis, the carrying value of the Food Safety and Animal Safety reporting units exceeded its fair value as of March 1, 2025. Accordingly, impairment charges of $584.8 million and $13.1 million were recorded for the Food Safety and Animal Safety reporting units, respectively. The fourth quarter impairment charges were primarily caused by overall financial performance. Differences in the balance sheet change and impairment charge are due to foreign exchange.

Fair value of the reporting unit was estimated based on a combination of an income-based approach, consisting of a discounted cash flows analysis, and a market-based approach, consisting of pricing multiples derived from an analysis of comparable public companies multiplied against historical and/or anticipated financial metrics of the reporting unit. The inputs to the fair value are defined in the fair value hierarchy as Level 3 inputs.

The following table summarizes goodwill by reportable segment:


	Food Safety			Animal Safety			Total
Balance, May 31, 2024	$	2,054.2		$	81.4		$	2,135.6
Impairment		(1,045.3	)		(13.1	)		(1,058.4	)
Foreign currency translation and other (1)		(12.0	)		(0.3	)		(12.3	)
Balance, May 31, 2025	$	996.9		$	68.0		$	1,064.9
Foreign currency translation and other (1)		5.2			(22.9	)		(17.7	)
Balance, May 31, 2026	$	1,002.1		$	45.1		$	1,047.2

(1) Other includes goodwill related to held for sale entities, which was reclassified within Assets held for sale.

Definite-lived intangible assets consisted of the following and are included in amortizable intangible assets within the consolidated balance sheets:


	Gross Carrying Amount		Less Accumulated Amortization		Net Carrying Amount
Licenses	$	15.0	$	7.1	$	7.9
Covenants not to compete		0.3		0.2		0.1
Patents		9.0		4.6		4.4
Customer relationships intangibles		1,222.1		250.9		971.2
Trade names and trademarks		118.2		22.0		96.2
Developed technology		306.6		82.5		224.1
Other product and service-related intangibles		15.7		1.6		14.1
Balance, May 31, 2026	$	1,686.9	$	368.9	$	1,318.0

Licenses	$	15.6	$	7.8	$	7.8
Covenants not to compete		0.4		0.3		0.1
Patents		8.9		4.4		4.5
Customer relationships intangibles		1,231.9		196.7		1,035.2
Trade names and trademarks		119.2		16.4		102.8
Developed technology		307.9		62.3		245.6
Other product and service-related intangibles		16.4		1.9		14.5
Balance, May 31, 2025	$	1,700.3	$	289.8	$	1,410.5

Amortization expense for intangibles totaled $91.8 million, $93.9 million, and $94.9 million in fiscal years 2026, 2025, and 2024, respectively. During fiscal year 2024, the Company recorded an impairment of $0.6 million to its amortizable licenses related to discontinued product lines.

Estimated amortization expense for fiscal years: 2027—$93.9 million, 2028—$93.0 million, 2029—$89.4 million, 2030—$88.4 million, 2031—$87.8 million, 2032 and thereafter—$865.5 million

During the fourth quarter of fiscal year 2025, the Company identified that recent overall financial performance of its asset groups represented a triggering event to test long-lived assets for impairment as of March 1, 2025. Management utilized a third-party to quantitatively assess its asset groups with an undiscounted cash flow analysis. Based on the results of the analysis, the undiscounted cash flows of the asset groups exceeded their carrying value.

In fiscal year 2024, the non-amortizable intangible assets were reclassified to definite-lived intangible assets. In conjunction with the reclassification, management completed an impairment analysis of the intangible assets using a qualitative assessment and determined that recorded amounts were not impaired.